Canada Pension Plan Investment Board’s Ascendis Pharma A/S ASND Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.01M	Sell	30,663 -40,853	-57%	-$9.16M	﹤0.01%	720
2025 Q4	$15.3M	Buy	71,516 +44,985	+170%	+$9.29M	0.01%	558
2025 Q3	$5.27M	Buy	+26,531	New	+$4.95M	﹤0.01%	752
2019 Q3	–	Sell	-11,100	Closed	-$1.28M	–	1189
2019 Q2	$1.28M	Buy	+11,100	New	+$1.33M	﹤0.01%	1011

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Canada Pension Plan Investment Board's ASND Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Ascendis Pharma A/S (ASND) stake by 57% in Q1 2026, selling an estimated $9.16M and leaving 30,663 shares worth $7.01M. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Canada Pension Plan Investment Board first reported a position in ASND in Q2 2019 and has held it in 4 quarters since. The position peaked at $15.3M in Q4 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Canada Pension Plan Investment Board held 30,663 shares of Ascendis Pharma A/S worth $7.01M as of Q1 2026.
Canada Pension Plan Investment Board sold 40,853 Ascendis Pharma A/S shares in Q1 2026, an estimated $9.16M.
Ascendis Pharma A/S made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #720 holding.
Canada Pension Plan Investment Board first reported a position in Ascendis Pharma A/S in Q2 2019 and has held it in 4 quarters since.
Canada Pension Plan Investment Board's Ascendis Pharma A/S position peaked at $15.3M in Q4 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.